Monte Rosa Therapeutics, Inc. (GLUE)
17.80
-0.15
(-0.84%)
USD |
NASDAQ |
Mar 06, 16:00
17.79
-0.01
(-0.06%)
After-Hours: 20:00
Monte Rosa Therapeutics Cash from Investing (TTM) : -67.66M for Sept. 30, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Amicus Therapeutics, Inc. | -46.43M |
| Pfizer Inc. | -1.351B |
| CorMedix, Inc. | -308.43M |
| Kura Oncology, Inc. | -13.10M |
| Alumis, Inc. | 223.81M |